Lataa...
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy
The risk of infection in patients receiving immune checkpoint inhibitor (ICI) therapy is not well understood. Immune‐related adverse events requiring immunosuppressive therapy may impact infection risk. ICIs may induce an exaggerated immune response to latent infection. We assessed the incidence and...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724496/ https://ncbi.nlm.nih.gov/pubmed/33159505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3532 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|